Home » Clinical Trials » Search Clinical Trials
Parent Therapeutic Areas: Oncology
Solid Tumors
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
A Phase I Study of Bortezomib and Temozolomide in Patients with Refractory Solid Tumors
A Phase I Trial of PS-341 in Combination with Topotecan in Advanced Solid Tumor Malignancies
A Prospective, Randomized Trial Comparing the Efficacy of Anidulafungin and Voriconazole in Combination to that of Voriconazole Alone When Used for Primary Therapy of Proven or Probable Invasive Aspergillosis
A Randomized, Double-Blind Active Controlled Crossover Study to Evaluate the Efficacy and Safety of Fentanyl Buccal Tablets Compared with Immediate-Release Oxycodone for the Management of Breakthrough Pain in Opioid-Tolerant Patients with Chronic Pain
COG ACCRN07: Protocol for the Enrollment on the Official COG Registry, the Childhood Cancer Research Network (CCRN) for Groupwide Participation
COG ALTE03N1: Key Adverse Events After Childhood Cancer
Dasatinib with Ifosfamide, Carboplatin, Etoposide: A Pediatric Phase I/II Trial
Evaluation of BCL-XL Specific Immunity
Innovative Underserved Community-Based Cancer Risk Screening
Passport for Care: Implementation in Multiple Institutions
Phase I Trial of Intraperitoneal nab-Paclitaxel (Abraxane) in the Treatment of Advanced Malignancies Primarily Confined to the Peritoneal Cavity
Phase I/II Study of a Triplet Combination of CBP501, Pemetrexed and Cisplatin in Patients with Advanced Solid Tumors and in Chemotherapy-Naive Patients with Malignant Pleural Mesothelioma
PHI-52 NCI#7225: A Phase I and Pharmacokinetic Study of Oral 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone (3-AP, Triapine)in the Treatment of Advanced Solid Tumors
PHI-53 NCI#7251: A Phase I Trial of PXD101 in Combination with 13-cis-Retinoic Acid in Advanced Solid Tumor Malignancies
PHI-54 NCI #7540: Phase I Trial of Intravenous Fenretinide (4-HPR) for Patients with Malignant Solid Tumors
PHI-55 NCI#7427: A Phase I Study of Halichondrin B Analog (E7389) in Combination with Cisplatin in Advanced Solid Tumors
PHI-60 NCI#8063: A Phase I and Pharmacokinetic Single Agent Study of Pazopanib in Patients with Advanced Malignancies and Varying Degrees of Liver Dysfunction
PHI-61 NCI#7967: A Phase I Study of ABT-888 in Combination with Carboplatin and Paclitaxel in Advanced Solid Malignancies
PHI-62: NCI# 8275: A Phase I Study of ABT-888 in Combination with Metronomic Cyclophosphamide in Adults with Refractory Solid Tumors and Lymphomas
Pilot Study of Dose Adjustment of Vinorelbine in Patients with Varying Degree of Liver Dysfunction
SWOG S0528: Phase I Study Evaluating the Combination of Lapatinib (GW572016 NSC-727989, IND-75,093) and Everolimus(RAD001; NSC-733504; IND 75, 093) in Patients with Advanced Solid Tumors
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
A Phase 1 Study of Bavituximab in Patients with Solid Tumors
A Phase 1 Study of S-1 Administered in Combination with Taxotere
A Phase 1 Study of STA-9090, Administered Once-Weekly in Patients with Solid Tumors
A Phase 2 Study of ARQ 197 in Patients with Microphthalmia Transciption Factor Associated Tumors
A Phase I Dose Finding Study of TRC105 in Patients with Advanced or Metastatic Solid Cancer
A Phase I Dose-Escalation Study of SCH900776 as Monotherapy and in Combination with Gemcitabine in Subjects with Advanced Solid Tumors or Lymphoma
A Phase I Study of AMG 479 in Combination with either Nexavar or Erlotinib
A Phase I Study of ARQ 197 in Combination with Tarceva in Patients with Advanced Solid Tumors
A Phase I Study of Asonep in Subjects with Refractory Advanced Solid Tumors
A Phase I Study of BIIB015 in Patients with Cripto-Positive Solid Tumors
A Phase I Study of BIIB021 Administered Once or Twice Daily to Subjects with Advanced Solid Tumors
A Phase I Study of CP751,871 + Sutent in Patients with Advanced Solid Tumors
A Phase I Study of IPI-493 in Patients with Advanced Malignancies
A Phase I Study of MP470 in Combination with Standard of Care Chemotherapy Regimens
A Phase I Study of SSR244738 (TED5799) in Patients with Refractory Solid Tumors
A Phase I Study of the HSP90 Inhibitor STA-9090 in Patients with Solid Tumors
A Phase I Study of TRC102 in Combination with Alimta in Patients with Advanced Solid Tumors
A Phase I Study of XL518 in Subjects with Advanced Solid Tumors
A Phase I Trial of CVX-060, an Anti-Angiogenic COVX-BODY in Patients with Advanced Solid Tumors
A Study Evaluating the Pharmacokinetics of S-1 in patients with impaired renal function
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
A Phase I Investigation of the Safety, Tolerability and Immunogenicity of V934/V935 hTERT Vaccination in Cancer Patients With Selected Solid Tumors
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
A Phase 1b Trial of the Combination of Bryostatin-1 and Low Dose Interleukin-2: Evaluation of the Functional and Molecular Status of Human Monocytes as Antigen Presenting cells
An open-label dose escalation study of patients with solid tumors treated with STA-9090
An open-label dose escalation study of patients with solid tumors treated with STA-9090
An open-label dose escalation study of patients with solid tumors treated with STA-9090
An open-label dose escalation study of patients with solid tumors treated with STA-9090
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
(ADVL0714) A Phase I Study of VEGF Trap in Children with Refractory Solid Tumors
(ADVL0812) A Phase I Study of MLN8237, an Oral Selective Small Molecule Inhibitor of Aurora A Kinase, in Children with Relapsed/Refractory Solid Tumors and Leukemia
A Phase 1 Study of SAHA in Pediatric Patients with Recurrent or Refractory Solid Tumors (Including Lymphomas) and Leukemia Followed by a Phase I Study of SAHA in Combination with 13 Cis-Retinoic Acid for Patients with Selected Recurrent/Refractory Solid Tumors
A Phase I Study of IMC-A12 (Anti-IGF-I Receptor Monoclonal Antibody) in Children with Relapsed/Refractory Solid Tumors
A Phase II Study of Sulindac and Tamoxifen in Patients with Desmoid Tumors that are Recurrent or Not Amenable to Standard Therapy
A Phase Study of Temozolomide, Oral Irinotecan, and Vincristine for Children with Refractory Solid Tumors
A Phase Study of Temozolomide, Oral Irinotecan, and Vincristine for Children with Refractory Solid Tumors
ADVL0612: A Phase I Study of Sunitinib (SU11248), an Oral Multi-Targeted Tyrosine Kinase Inhibitor, in Children with Refractory Solid Tumors
Phase I Study of the RAF Kinase and Receptor Tyrosine Kinase Inhibitor Sorafenib in Children with Refractory Solid Tumors or Refractory Leukemias
VITAC: A Pilot Study of the Addition of Bevacizumab to Vincristine, Oral Irinotecan and Temozolomide (VOIT regiment) for Relapsed/Refractory Pediatric Solid Tumors
A Phase 1 Study of STA-9090, Administered Once-Weekly in Patients with Solid Tumors
A Phase I Investigation of the Safety, Tolerability and Immunogenicity of V934/V935 hTERT Vaccination in Cancer Patients With Selected Solid Tumors
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
A Phase I Investigation of the Safety, Tolerability and Immunogenicity of V934/V935 hTERT Vaccination in Cancer Patients With Selected Solid Tumors
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
Study to evaluate the clinical benefit response of a new drug AMT vs Placebo in advanced cancer patients with esophagus, colon, pancreas, lung, gastric, liver, gall bladder, prostate and female reproductive system cancers
